Details of the Drug

General Information of Drug (ID: DMES7JY)

Drug Name

Midecamycin

Synonyms

midecamycin; Mydecamycin; Medemycin; Turimycin P3; Antibiotic SF 837; SF 837; YL 704 B1; 35457-80-8; Antibiotic YL 704B1; Antibitotic YL-704 B1; Prestwick_515; Antibiotic SF-837; AC1NTK8S; Prestwick2_000153; Leucomycin V,4B-dipropanoate; HMS1568O08; NSC154011; NSC-154011; LEUCOMYCIN V - RELATED TO D239737 - MEIJI SEIKA

Indication

Disease Entry	ICD 11	Status	REF
Bacterial infection	1A00-1C4Z	Approved	[1]
------------------------------------------------------------------------------------

Affected Organisms

Gram-positive BacteriaBordetella pertussisCorynebacterium diphtheriaeStreptococcus pneumoniaeHaemophilus influenzaeStaphylococcus haemolyticusMycoplasma pneumoniae

ATC Code

J01FA03: Midecamycin

J01FA: Macrolides

J01F: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS

J01: ANTIBACTERIALS FOR SYSTEMIC USE

J: ANTIINFECTIVES FOR SYSTEMIC USE

J01FA03: Midecamycin

J01FA: Macrolides

J01F: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS

J01: ANTIBACTERIALS FOR SYSTEMIC USE

J: ANTIINFECTIVES FOR SYSTEMIC USE

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C41H67NO15
Canonical SMILES: CCC(=O)OC1CC(=O)OC(CC=CC=CC(C(CC(C(C1OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC)(C)O)N(C)C)O)CC=O)C)O)C
InChI: 1S/C41H67NO15/c1-11-30(45)54-29-21-32(47)51-24(4)16-14-13-15-17-28(44)23(3)20-27(18-19-43)37(38(29)50-10)57-40-35(48)34(42(8)9)36(25(5)53-40)56-33-22-41(7,49)39(26(6)52-33)55-31(46)12-2/h13-15,17,19,23-29,33-40,44,48-49H,11-12,16,18,20-22H2,1-10H3/b14-13+,17-15+/t23-,24-,25-,26+,27+,28+,29-,33+,34-,35-,36-,37+,38+,39+,40+,41-/m1/s1
InChIKey: DMUAPQTXSSNEDD-QALJCMCCSA-N

Cross-matching ID

PubChem CID: 5282169
ChEBI ID: CHEBI:31845
CAS Number: 35457-80-8
UNII: N34Z0Y5UH7
DrugBank ID: DB13456
TTD ID: D0J7OG

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015